NANOBIOTIX appoints senior executive from pharmaceutical industry, as Chief Operating Officer

Paris, France and Cambridge, Massachusetts, USA, February 7, 2017 – NANOBIOTIX , a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announced today the appointment of Alain Dostie, a senior executive from the pharmaceutical industry, as its Chief Operating Officer . Mr. Dostie will lead Nanobiotix’s operations, including development, manufacturing, market access and sales, for the Company’s lead product NBTXR3, which could obtain a CE Mark approval in 2017.

Research highlights need to improve sleep for homeless people

The homeless sleep less and are more likely to have insomnia and daytime fatigue than people in the general population, findings researchers believe suggest more attention needs to be paid to improving sleep for this vulnerable population, according to a research letter published online by JAMA Internal Medicine . Sleep is part of good health, but the homeless often have no access to safe and warm beds at night.